Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management

Clinical article

Restricted access

Object

There are a variety of treatment options for the management of vestibular schwannomas (VSs), including microsurgical resection, radiotherapy, and observation. Although the choice of treatment is dependent on various patient factors, physician bias has been shown to significantly affect treatment choice for VS. In this study the authors describe the current epidemiology of VS and treatment trends in the US in the modern era. They also illustrate patient and tumor characteristics and elucidate their effect on tumor management.

Methods

Patients diagnosed with VS were identified through the Surveillance, Epidemiology, and End Results database, spanning the years 2004–2009. Age-adjusted incidence rates were calculated and adjusted using the 2000 US standard population. The chi-square and Student t-tests were used to evaluate differences between patient and tumor characteristics. Multivariate logistic regression was performed to determine the effects of various patient and tumor characteristics on the choice of tumor treatment.

Results

A total of 6225 patients with VSs treated between 2004 and 2009 were identified. The overall incidence rate was 1.2 per 100,000 population per year. The median age of patients with VS was 55 years, with the majority of patients being Caucasian (83.16%). Of all patients, 3053 (49.04%) received surgery only, with 1466 (23.55%) receiving radiotherapy alone. Both surgery and radiation were only used in 123 patients (1.98%), with 1504 patients not undergoing any treatment (24.16%). Increasing age correlated with decreased use of surgery (OR 0.95, 95% CI 0.95–0.96; p < 0.0001), whereas increasing tumor size was associated with the increased use of surgery (OR 1.04, 95% CI 1.04–1.05; p < 0.0001). Older age was associated with an increased likelihood of conservative management (OR 1.04, 95% CI 1.04–1.05; p < 0.0001). Racial disparities were also seen, with African American patients being significantly less likely to receive surgical treatment compared with Caucasians (OR 0.50, 95% CI 0.35–0.70; p < 0.0001), despite having larger tumors at diagnosis.

Conclusions

The incidence of vestibular schwannomas in the US is 1.2 per 100,000 population per year. Although many studies have demonstrated improved outcomes with the use of radiotherapy for small- to medium-sized VSs, surgery is still the most commonly used treatment modality for these tumors. Racial disparities also exist in the treatment of VSs, with African American patients being half as likely to receive surgery and nearly twice as likely to have their VSs managed conservatively despite presenting with larger tumors. Further studies are needed to elucidate the reasons for treatment disparities and investigate the nationwide trend of resection for the treatment of small VSs.

Abbreviations used in this paper:SEER = Surveillance, Epidemiology, and End Results; VS = vestibular schwannoma.

Article Information

Address correspondence to: Cory Adamson, M.D., Ph.D., M.P.H., M.H.Sc., Division of Neurosurgery, DUMC 3807, Durham, North Carolina 27710. email: cory.adamson@duke.edu.

Please include this information when citing this paper: published online February 22, 2013; DOI: 10.3171/2013.1.JNS121370.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Graph showing decreased use of surgery and increased use of radiotherapy and observation for the management of VS.

  • View in gallery

    Left: Preoperative Gd-enhanced MRI study demonstrating an avidly enhancing mass at the left cerebellopontine angle, suggesting a VS. Right: Postoperative MRI study demonstrating a so-called function-preserving approach, with a silhouette of residual tumor left along the facial nerve.

References

1

Agrawal YClark JHLimb CJNiparko JKFrancis HW: Predictors of vestibular schwannoma growth and clinical implications. Otol Neurotol 31:8078122010

2

Arthurs BJFairbanks RKDemakas JJLamoreaux WTGiddings NAMackay AR: A review of treatment modalities for vestibular schwannoma. Neurosurg Rev 34:2652792011

3

Arthurs BJLamoreaux WTMackay ARDemakas JJGiddings NAFairbanks RK: Gamma knife radiosurgery for vestibular schwannomas: tumor control and functional preservation in 70 patients. Am J Clin Oncol 34:2652692011

4

Bakkouri WEKania REGuichard JPLot GHerman PHuy PT: Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. Clinical article. J Neurosurg 110:6626692009

5

Breivik CNVarughese JKWentzel-Larsen TVassbotn FLund-Johansen M: Conservative management of vestibular schwannoma—a prospective cohort study: treatment, symptoms, and quality of life. Neurosurgery 70:107210802012

6

Charabi STos MThomsen JCharabi BMantoni M: Vestibular schwannoma growth—long-term results. Acta Otolaryngol Suppl 543:7102000

7

Chopra RKondziolka DNiranjan ALunsford LDFlickinger JC: Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 68:8458512007

8

Christensen HCSchüz JKosteljanetz MPoulsen HSThomsen JJohansen C: Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol 159:2772832004

9

Cooper GSVirnig BKlabunde CNSchussler NFreeman JWarren JL: Use of SEER-Medicare data for measuring cancer surgery. Med Care 40:8 SupplIV-43IV-482002

10

Curry WT JrCarter BSBarker FG II: Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988–2004. Neurosurgery 66:4274382010

11

DeLong MKaylie DKranz PGAdamson DC: Vestibular schwannomas: lessons for the neurosurgeon: part I: diagnosis, neuroimaging, and audiology. Contemp Neurosurg 33:20152011

12

DeLong MKirkpatrick JCummings TAdamson DC: Vestibular schwannomas: lessons for the neurosurgeon: part II: molecular biology and histology. Contemp Neurosurg 33:21132011

13

Flickinger JCKondziolka DNiranjan AMaitz AVoynov GLunsford LD: Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 60:2252302004

14

Gal TJShinn JHuang B: Current epidemiology and management trends in acoustic neuroma. Otolaryngol Head Neck Surg 142:6776812010

15

Godefroy WPKaptein AAVogel JJvan der Mey AG: Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome. Otol Neurotol 30:9689742009

16

Hardell LHansson Mild KSandström MCarlberg MHallquist APåhlson A: Vestibular schwannoma, tinnitus and cellular telephones. Neuroepidemiology 22:1241292003

17

Hasegawa TFujitani SKatsumata SKida YYoshimoto MKoike J: Stereotactic radiosurgery for vestibular schwannomas: analysis of 317 patients followed more than 5 years. Neurosurgery 57:2572652005

18

Howitz MFJohansen CTos MCharabi SOlsen JH: Incidence of vestibular schwannoma in Denmark, 1977–1995. Am J Otol 21:6906942000

19

Inskip PDTarone REHatch EEWilcosky TCShapiro WRSelker RG: Cellular-telephone use and brain tumors. N Engl J Med 344:79862001

20

INTERPHONE Study Group: Acoustic neuroma risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Cancer Epidemiol 35:4534642011

21

Kaltoft MStangerup SECaye-Thomasen P: Facial nerve function after vestibular schwannoma surgery following failed conservative management. Neurosurgery 70:2782822012

22

Kaylie DMHorgan MJDelashaw JBMcMenomey SO: A meta-analysis comparing outcomes of microsurgery and gamma knife radiosurgery. Laryngoscope 110:185018562000

23

Larjavaara SFeychting MSankila RJohansen CKlaeboe LSchüz J: Incidence trends of vestibular schwannomas in Denmark, Finland, Norway and Sweden in 1987–2007. Br J Cancer 105:106910752011

24

Lönn SAhlbom AHall PFeychting M: Mobile phone use and the risk of acoustic neuroma. Epidemiology 15:6536592004

25

Lunsford LDNiranjan AFlickinger JCMaitz AKondziolka D: Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg 102:Suppl1951992005

26

Malhotra PSSharma PFishman MAGrumbine FLTholey RDam VQ: Clinical, radiographic, and audiometric predictors in conservative management of vestibular schwannoma. Otol Neurotol 30:5075142009

27

Malin JLKahn KLAdams JKwan LLaouri MGanz PA: Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94:8358442002

28

Martin TPFox HHo ECHolder RWalsh RIrving RM: Facial nerve outcomes in functional vestibular schwannoma surgery: less than total tumour excision significantly improves results. J Laryngol Otol 126:1201242012

29

McClelland S IIIGuo HOkuyemi KS: Morbidity and mortality following acoustic neuroma excision in the United States: analysis of racial disparities during a decade in the radiosurgery era. Neuro Oncol 13:125212592011

30

Mukherjee DZaidi HAKosztowski TChaichana KLBrem HChang DC: Disparities in access to neuro-oncologic care in the United States. Arch Surg 145:2472532010

31

Myrseth EMøller PPedersen PHLund-Johansen M: Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery 64:6546632009

32

Myrseth EMøller PPedersen PHVassbotn FSWentzel-Larsen TLund-Johansen M: Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery 56:9279352005

33

Patel HRMirsadraee SEmberton M: The patient's dilemma: prostate cancer treatment choices. J Urol 169:8288332003

34

Pogodzinski MSHarner SGLink MJ: Patient choice in treatment of vestibular schwannoma. Otolaryngol Head Neck Surg 130:6116162004

35

Pollock BEDriscoll CLFoote RLLink MJGorman DABauch CD: Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59:77852006

36

Preston-Martin SThomas DCWright WEHenderson BE: Noise trauma in the aetiology of acoustic neuromas in men in Los Angeles County, 1978–1985. Br J Cancer 59:7837861989

37

Propp JMMcCarthy BJDavis FGPreston-Martin S: Descriptive epidemiology of vestibular schwannomas. Neuro Oncol 8:1112006

38

Régis JDelsanti CRoche PHThomassin JMPellet W: [Functional outcomes of radiosurgical treatment of vestibular schwannomas: 1000 successive cases and review of the literature.]. Neurochirurgie 50:3013112004. (Fr)

39

Ron EModan BBoice JD JrAlfandary EStovall MChetrit A: Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:103310391988

40

Samii MMatthies C: Management of 1000 vestibular schwannomas (acoustic neuromas): the facial nerve—preservation and restitution of function. Neurosurgery 40:6846951997

41

Schmitt WRCarlson MLGiannini CDriscoll CLLink MJ: Radiation-induced sarcoma in a large vestibular schwannoma following stereotactic radiosurgery: case report. Neurosurgery 68:E840E8462011

42

Selesnick SHJohnson G: Radiologic surveillance of acoustic neuromas. Am J Otol 19:8468491998

43

Sherwood PRDahman BADonovan HSMintz AGiven CWBradley CJ: Treatment disparities following the diagnosis of an astrocytoma. J Neurooncol 101:67742011

44

Shin YJLapeyre-Mestre MGafsi ICognard CDeguine OTremoulet M: Neurotological complications after radiosurgery versus conservative management in acoustic neuromas: a systematic review-based study. Acta Otolaryngol 123:59642003

45

Smouha EEYoo MMohr KDavis RP: Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope 115:4504542005

46

Stangerup SECaye-Thomasen PTos MThomsen J: The natural history of vestibular schwannoma. Otol Neurotol 27:5475522006

47

Stangerup SEThomsen JTos MCayé-Thomasen P: Longterm hearing preservation in vestibular schwannoma. Otol Neurotol 31:2712752010

48

Stangerup SETos MThomsen JCaye-Thomasen P: True incidence of vestibular schwannoma?. Neurosurgery 67:133513402010

49

Sughrue MEYang IAranda DRutkowski MJFang SCheung SW: Beyond audiofacial morbidity after vestibular schwannoma surgery. Clinical article. J Neurosurg 114:3673742011

50

Suryanarayanan RRamsden RTSaeed SRAggarwal RKing ATRutherford SA: Vestibular schwannoma: role of conservative management. J Laryngol Otol 124:2512572010

51

Tos MCharabi SThomsen J: Incidence of vestibular schwannomas. Laryngoscope 109:7367401999

52

Tos MStangerup SECayé-Thomasen PTos TThomsen J: What is the real incidence of vestibular schwannoma?. Arch Otolaryngol Head Neck Surg 130:2162202004

53

Varughese JKBreivik CNWentzel-Larsen TLund-Johansen M: Growth of untreated vestibular schwannoma: a prospective study. Clinical article. J Neurosurg 116:7067122012

54

Virnig BAWarren JLCooper GSKlabunde CNSchussler NFreeman J: Studying radiation therapy using SEER-Medicare-linked data. Med Care 40:8 SupplIV-49IV-542002

55

Weber DCChan AWBussiere MRHarsh GR IVAncukiewicz MBarker FG II: Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery 53:5775882003

56

Whitmore RGUrban CChurch ERuckenstein MStein SCLee JY: Decision analysis of treatment options for vestibular schwannoma. Clinical article. J Neurosurg 114:4004132011

57

Yamakami IUchino YKobayashi EYamaura A: Conservative management, gamma-knife radiosurgery, and microsurgery for acoustic neurinomas: a systematic review of outcome and risk of three therapeutic options. Neurol Res 25:6826902003

58

Yanamadala VWilliamson RFusco DJEschbacher JWeisskopf PPorter R: Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery: case report and review of the literature. World Neurosurg [epub ahead of print]2012

59

Yang TRockhill JBorn DESekhar LN: A case of high-grade undifferentiated sarcoma after surgical resection and stereotactic radiosurgery of a vestibular schwannoma. Skull Base 20:1791832010

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 216 216 60
Full Text Views 273 273 21
PDF Downloads 222 222 18
EPUB Downloads 0 0 0

PubMed

Google Scholar